For press inquiries click here to contact us.
GRAIL, Inc.
Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal
Evonetix
Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices
Lyell Immunopharma
Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors
Cerevance
Biotech Startup Cerevance Extends Series B to $65 Million
Kinnate Biopharma
Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer
Inscripta
Writing in the Language of DNA: Kevin Ness on The Long Run
Relay Therapeutics
Relay Therapeutics tees up $200M IPO to push a trio of oncology meds
Bit Bio Limited
Sure, Bit Bio got some significant cash for its cell coding work. But it’s the insiders who are backing them that will garner the attention
DNAnexus, Inc.
DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data
Please see important disclaimers in the Terms section.
